Russo Gregg sold (to issuer) $15K of CPRX
Russo Gregg (Chief HR Officer) sold (to issuer) 476 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 on 2026-07-15.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider activity but does not introduce new company-specific catalysts such as trial results, guidance, financing, or regulatory actions.
Market read
Traders may note insider selling, but the transaction size and lack of new fundamentals make it low signal.
What to watch
No 10b5-1 plan is stated, but the filing does not provide context for motivation; the post-transaction holding is 0 shares, which can be consistent with planned diversification or compensation mechanics.
Background
The filing is a SEC Form 4 insider transaction for Catalyst Pharmaceuticals, Inc. (CPRX).
Ticker impact
Catalyst Pharmaceuticals insider Russo Gregg sold 476 shares to the issuer at $31.50 on 2026-07-15, leaving 0 shares.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.
Form 4 shows a small, single-transaction sale (about $15k) and does not include new operational, financial, or regulatory information.
Market effects
No clear read-across to the biotech sector from a small Form 4 insider sale.
None.
None.
Counterpoint
The sale could be administrative or liquidity-driven (sale to issuer) and may not signal reduced confidence.
Key entities
- issuerCATALYST PHARMACEUTICALS, INC.
CPRX, the company whose insider transaction was reported.
- insiderRusso Gregg
Chief HR Officer who sold 476 shares to the issuer.